GSDMD showed risk in CD4+ naïve/central‐memory T cells for AS and PsO, opposite effects in non‐classical monocytes (protection in BD, risk in PSC), and protection in natural killer cells (BD) and plasma cells (UC) (Figure 1C). The gene discussed is CD4; the disease is Behcet disease.